RAPP · Company research
Rapport Therapeutics, Inc. (RAPP): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania | Rapport Therapeutics announced positive Phase 2 trial results for RAP-219 in treating acute bipolar mania, meeting primary and secondary endpoints with statistically significant placebo-adjusted improvements in YMRS scores (3.1 points, p=0.045) and CGI-BP mania severity (0.4 points, p=0.024). The drug demonstrated favorable tolerability with no severe adverse events, establishing clinical proof-of-concept for its novel TARPγ8-selective mechanism. Phase 3 trials are expected to begin in the second half of 2027. | View source ↗ | GlobeNewswire Inc. | Oct 20, 2026 | bullish | 1 | 1 |
| Rapp Shares Perspective on AI in the Classroom – KCSR / KBPY - chadronradio.com | Rapp Shares Perspective on AI in the Classroom – KCSR / KBPY chadronradio.com | View source ↗ | chadronradio.com | Oct 19, 2026 | neutral | 0 | 0.6 |
| (RAPP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily | (RAPP) Movement Within Algorithmic Entry Frameworks Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 16, 2026 | neutral | 0 | 0.6 |
| RAPP May 2027 60.000 call (RAPP270521C00060000) Stock Historical Prices & Data - Yahoo! Finance Canada | RAPP May 2027 60.000 call (RAPP270521C00060000) Stock Historical Prices & Data Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| RAPP May 2027 60.000 call (RAPP270521C00060000) Interactive Stock Chart - Yahoo! Finance Canada | RAPP May 2027 60.000 call (RAPP270521C00060000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| Stock replaces Q3 cash retainer as Xos (XOS) director acquires 1,814 shares. - Stock Titan | Stock replaces Q3 cash retainer as Xos (XOS) director acquires 1,814 shares. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| RAPP May 2027 60.000 call (RAPP270521C00060000) Stock Price, News, Quote & History - Yahoo! Finance Canada | RAPP May 2027 60.000 call (RAPP270521C00060000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 12, 2026 | neutral | 0 | 0.6 |
| Understanding the Setup: (RAPP) and Scalable Risk - Stock Traders Daily | Understanding the Setup: (RAPP) and Scalable Risk Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 6, 2026 | neutral | 0 | 0.6 |
| RAPP Oct 2026 47.500 put (RAPP261016P00047500) Stock Price, News, Quote & History - Yahoo! Finance Canada | RAPP Oct 2026 47.500 put (RAPP261016P00047500) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 4, 2026 | neutral | 0 | 0.6 |
| Rapport Therapeutics Inc (RAPP-Q) Stock Price and News - The Globe and Mail | Rapport Therapeutics Inc (RAPP-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Oct 1, 2026 | neutral | 0 | 0.6 |
| RAPP Form 4 Filings - Rapport Therapeutics, Inc. SEC Form 4 - Stock Titan | RAPP Form 4 Filings - Rapport Therapeutics, Inc. SEC Form 4 Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| Rapport: Bipolar Mania Readout May Distort True Value Of Anti-Seizure Med - Rating Upgrade - Seeking Alpha | Rapport: Bipolar Mania Readout May Distort True Value Of Anti-Seizure Med - Rating Upgrade Seeking Alpha | View source ↗ | Seeking Alpha | Sep 24, 2026 | neutral | 0 | 0.6 |
| $RAPP stock is down 10% today. Here's what we see in our data. - Quiver Quantitative | $RAPP stock is down 10% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 23, 2026 | neutral | 0 | 0.6 |
| Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania - Slideshow - Seeking Alpha | Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania - Slideshow Seeking Alpha | View source ↗ | Seeking Alpha | Sep 23, 2026 | neutral | 0 | 0.6 |
| Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now? - Yahoo Finance | Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 16, 2026 | neutral | 0 | 0.6 |
| BTIG Raises its Price Target on Rapport Therapeutics (RAPP) - Yahoo Finance | BTIG Raises its Price Target on Rapport Therapeutics (RAPP) Yahoo Finance | View source ↗ | Yahoo Finance | Jun 5, 2026 | neutral | 0 | 0.6 |
| RAPP Stock Price and Chart — NASDAQ:RAPP - TradingView | RAPP Stock Price and Chart — NASDAQ:RAPP TradingView | View source ↗ | TradingView | May 8, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.